$SFOR You don’t need extraordinary intelligence to
$SFOR You don’t need extraordinary intelligence to succeed as an investor. We just have to be smarter than the rest & have to be more disciplined than the rest. While some peeps mistakenly consider value investing a mechanical tool for identifying bargains, it is actually a comprehensive investment philosophy that emphasizes the need to perform in-depth fundamental analysis, pursue long-term investment results, limit risk, and resist crowd psychology.
Investors here must know and understand that in the short run, the market is just like a voting machine, but in the long run it is a weighing machine. I am investing & buying here not on optimism, but on arithmetic/research/ future/analysis & growth that is weighted on SFOR's IP in cyber security ecosystem in the current marketplace.
It is remarkable how much long-term advantage investors like us have gotten by trying to be consistently not stupid, instead trying to be very diligent in their research.I always try to find and focus on few intelligent things to do & not to keep up with every damn thing in the world. This is the only reason, I have SFOR as my first micro cap play in over 20 years of investment experience, because I see something very unique here.
To me personally , all intelligent investing is value investing , acquiring more that I am paying for. Peeps here must value the business in order to value the stock & that's a bottom line
If peeps think investing is gambling they are doing it wrong. The work behind investing requires careful planning and patience. Investing should be more like watching paint dry or watching grass grow. If peeps want excitement they can take their $800 and go to Las Vegas.
Calling someone who trades actively in the market an investor is like calling someone who repeatedly engages in one-night stands a romantic.
We have an an unique opportunity, grab it while you can. Leave the clutter of the board in PM's so that it is easy for all of us to focus. My 2c
23
Zerify Inc (ZRFY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Top 5 Most Recently Viewed Articles
Enhancing Productivity for Salesforce Users Salesforce remains a cornerstone technology for countless businesses aiming to streamline customer relationship management processes. However, extracting the maximum value from Salesforce requires a deep understanding of its capabilities and a strategy tailored to maximize user productivity. This comprehensive guide provides...
Continue Reading
Burnett Homeopathy Summit 3 Unites Global Experts In a remarkable gathering, Burnett Homeopathy Pvt. Ltd. organized the much-anticipated World Homoeopathy Summit 3 in Köthen, Germany, which is often heralded as the epicenter of classical homeopathy. This significant event, celebrated around the birthday of Dr. Samuel Hahnemann, the Father of Homeopathy, saw the...
Continue Reading
Bioventus to Participate in Healthcare Conference Bioventus Inc. (NASDAQ: BVS), a leading company focused on active healing innovations, is set to participate in a significant healthcare gathering. Mark Singleton, the esteemed Senior Vice-President and Chief Financial Officer of Bioventus, will participate in an engaging fireside chat at the upcoming Morgan Stanley Global...
Continue Reading
The Thriving Dragon Boat Invitational Tournament in Shanghai The 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament wrapped up, boasting a remarkable record of participation. This vibrant event gathered numerous teams, showcasing the spirit of competition and camaraderie among the participants. A Record-Setting Participation This year's tournament saw the...
Continue Reading
Doubling Your Investment: A Look at Booz Allen Hamilton Investing in the stock market can lead to considerable financial growth, especially when investors choose dynamic companies like Booz Allen Hamilton (NYSE: BAH). Over the past five years, this company's stock has significantly outperformed the market, delivering impressive returns for its shareholders. Understanding...
Continue Reading